About
Antibodies
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibody
Clinical Trials (10)
View allTotal Trials
10
As Lead Sponsor
8
As Collaborator
2
Total Enrollment
1,086
By Phase
PHASE4: 1PHASE1: 5PHASE2: 3NA: 1
By Status
UNKNOWN: 3NOT_YET_RECRUITING: 2RECRUITING: 2COMPLETED: 2TERMINATED: 1
Clinical Trials Pipeline10 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT07098481Collaborator
Access to Hepatitis C Treatment in Cameroon: Comparison of a Simplified Test and Treat Strategy to a Standard Strategy
PHASE4Not yet recruiting
576 participants
Started: Sep 1, 2025 · Completed: Jun 30, 2028
NCT05957081Lead Sponsor
Study to Assess the Safety, Tolerability, and Blood Concentration of PMC-309
PHASE1Not yet recruiting
67 participants
Started: Nov 28, 2023 · Completed: Oct 4, 2028
NCT05953012Lead Sponsor
Study to Assess Safety and Tolerability of PMC-403 in Subjects With Neovascular Age-related Macular Degeneration
PHASE1Recruiting
36 participants
Started: Jul 20, 2023 · Completed: Oct 30, 2025
NCT04986852Lead Sponsor
Olinvacimab With Pembrolizumab in Patients With mTNBC
PHASE2Recruiting
30 participants
Started: Sep 30, 2021 · Completed: Aug 30, 2026
NCT03856099Lead Sponsor
TTAC-0001 Phase II Trial With Recurrent Glioblastoma Progressed on Bevacizumab
PHASE2Terminated
19 participants
Started: Nov 13, 2019 · Completed: Jul 15, 2022
Locations (1)
Headquarters
Daejeon, Korea
Map
Loading map...